data_1c0v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c0v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.439 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.41 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.727 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' ALA . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 14.5 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' CG ' ' O ' ' A' ' 43' ' ' PRO . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.428 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.604 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 77' ' ' ALA . 27.1 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.463 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' CG ' ' O ' ' A' ' 43' ' ' PRO . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 55' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 56' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 72' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 120.965 0.412 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.521 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 76' ' ' PHE . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' ALA . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.663 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.443 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.5 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 51' ' ' THR . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.727 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.579 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.449 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' O ' ' CG2' ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' C ' ' A' ' 19' ' ' LEU . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 61' ' ' ASP . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 16.4 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.487 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.577 ' CD ' ' C ' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.504 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' MET . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.407 ' ND2' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.596 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.593 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.515 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' ALA . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' HD22 ' A' ' 48' ' ' LEU . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 55' ' ' ILE . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 16.1 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 51' ' ' THR . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' HA3' ' CG1' ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.709 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.499 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.57 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 72' ' ' LEU . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.457 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 24' ' ' ALA . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.61 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.449 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.616 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.553 ' CD ' ' C ' ' A' ' 62' ' ' ALA . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.778 0.323 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.593 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 24' ' ' ALA . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.457 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HB3' HD13 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.548 ' HA ' ' CE ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.452 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.752 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.611 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 19.2 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.455 ' CE1' ' HG2' ' A' ' 50' ' ' ARG . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' THR . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.694 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.486 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.438 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.606 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 26' ' ' ILE . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' HA3' ' A' ' 58' ' ' GLY . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.499 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG12 ' A' ' 55' ' ' ILE . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.667 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.667 ' HG ' ' HA ' ' A' ' 56' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG11 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.521 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.614 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 61' ' ' ASP . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 26' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 24' ' ' ALA . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 30' ' ' ILE . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 35' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.649 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.53 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.649 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 51' ' ' THR . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.631 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.614 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG23 ' C ' ' A' ' 63' ' ' ILE . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.449 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.443 ' HA ' HG23 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 75' ' ' MET . 32.7 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.825 0.345 . . . . 1.0 111.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.83 -26.5 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.463 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.33 -47.25 7.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.22 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 pp -70.41 -10.09 58.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.3 -59.52 3.63 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.439 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.596 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.727 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.727 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' ALA . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 14.5 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' CG ' ' O ' ' A' ' 43' ' ' PRO . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.428 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA3' ' CG1' ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.604 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.561 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 77' ' ' ALA . 27.1 m -158.98 101.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.079 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 11.9 mmt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.856 0.36 . . . . 1.0 111.295 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -50.41 -29.48 10.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.214 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -109.24 -30.35 8.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.26 -10.22 59.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -73.16 -59.94 2.47 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.463 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' CG ' ' O ' ' A' ' 43' ' ' PRO . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 55' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 56' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 72' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.81 -32.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.103 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.512 0.196 . . . . 1.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 1' ' ' MET . 40.8 mt-10 84.65 -30.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -118.52 -34.07 4.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 111.115 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 3.4 tm? -67.02 -21.98 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.209 0.528 . . . . 0.0 109.719 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.89 -66.2 0.61 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.961 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.521 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 76' ' ' PHE . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.528 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' ALA . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.663 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.443 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.5 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' CE2' ' CE2' ' A' ' 35' ' ' PHE . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 51' ' ' THR . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.727 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.579 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.528 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.76 -64.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.12 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.812 0.339 . . . . 1.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -45.83 -36.14 5.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.87 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -111.83 -32.98 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.405 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 5.7 mp -72.95 -8.48 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.731 0.301 . . . . 0.0 111.035 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.74 -62.28 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.449 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' O ' ' CG2' ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' C ' ' A' ' 19' ' ' LEU . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 61' ' ' ASP . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 16.4 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.577 ' CD ' ' C ' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.504 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 75' ' ' MET . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.57 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.8 mtt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.527 0.203 . . . . 1.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 1' ' ' MET . 46.8 mt-10 83.79 -30.02 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.379 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -121.14 -32.52 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.617 0.246 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 5.4 mp -70.44 -16.64 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.178 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' ND2' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -70.44 -65.07 0.78 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.543 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.596 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.593 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.515 ' CB ' ' HB1' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' ALA . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HB2' HD22 ' A' ' 48' ' ' LEU . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 55' ' ' ILE . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 16.1 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 51' ' ' THR . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' HA3' ' CG1' ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.709 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' C ' ' CD ' ' A' ' 64' ' ' PRO . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.499 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.57 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 72' ' ' LEU . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.457 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' N ' HD21 ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.73 -64.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.083 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.816 0.341 . . . . 1.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -49.83 -27.04 4.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.544 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.61 -38.04 6.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.3 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.3 mp -74.58 -6.96 51.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.522 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.8 -59.71 2.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 24' ' ' ALA . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.463 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.61 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.449 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.616 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.553 ' CD ' ' C ' ' A' ' 62' ' ' ALA . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.529 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.453 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.21 -70.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.147 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.834 0.349 . . . . 1.0 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -48.9 -44.73 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.504 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -88.62 -33.62 17.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.13 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 5.6 mp -72.84 -12.16 60.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.32 -69.6 0.35 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.514 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.593 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 24' ' ' ALA . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.457 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HB3' HD13 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.548 ' HA ' ' CE ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.452 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 79' ' ' ALA . 11.9 p -106.57 -49.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.408 ' N ' HG13 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.569 0.223 . . . . 1.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 67.02 12.22 8.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.411 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -150.75 -57.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.605 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.9 mt -71.26 -7.91 50.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.652 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -70.52 -65.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.752 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 24' ' ' ALA . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.611 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.416 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.611 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 19.2 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.455 ' CE1' ' HG2' ' A' ' 50' ' ' ARG . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 51' ' ' THR . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.694 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.486 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 60' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 79' ' ' ALA . 12.0 p -104.07 -47.55 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' N ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 5.1 mmt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.726 0.298 . . . . 1.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 63.8 13.89 7.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.343 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -158.31 -45.5 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.82 -11.92 61.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.656 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -64.75 -60.42 3.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.438 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 72' ' ' LEU . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.606 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 26' ' ' ILE . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD11 ' HA3' ' A' ' 58' ' ' GLY . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.499 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG12 ' A' ' 55' ' ' ILE . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.667 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.667 ' HG ' ' HA ' ' A' ' 56' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.545 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG11 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.73 -39.3 77.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.104 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.724 0.297 . . . . 1.0 111.034 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 63.18 14.99 8.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -158.42 -44.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.711 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.12 -12.64 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.14 -68.18 0.42 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.11 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.521 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.614 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 61' ' ' ASP . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 26' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 24' ' ' ALA . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 30' ' ' ILE . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 35' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.53 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.649 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 51' ' ' THR . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HB3' ' HB1' ' A' ' 24' ' ' ALA . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.631 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.614 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG23 ' C ' ' A' ' 63' ' ' ILE . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.449 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.451 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.443 ' HA ' HG23 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 75' ' ' MET . 32.7 m -134.93 -46.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.448 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 75' ' ' MET . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' MET . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.591 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.751 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.744 HG23 ' HA ' ' A' ' 55' ' ' ILE . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 47' ' ' PRO . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 4.2 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.583 ' HB2' ' HB1' ' A' ' 39' ' ' ALA . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HA ' HG23 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.613 ' N ' HD11 ' A' ' 28' ' ' ILE . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.504 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.842 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 64' ' ' PRO . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.999 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD21 ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.848 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 78' ' ' VAL . 27.1 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 15' ' ' VAL . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 11' ' ' MET . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.886 ' CE ' HG23 ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' ILE . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.626 HD13 HG21 ' A' ' 51' ' ' THR . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' PRO . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.792 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 44' ' ' ASP . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.626 HG21 HD13 ' A' ' 36' ' ' LEU . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 31' ' ' LEU . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.636 ' HA ' HG23 ' A' ' 28' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.613 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.527 ' O ' HG12 ' A' ' 60' ' ' VAL . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.778 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.886 HG23 ' CE ' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.479 HG12 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 9' ' ' LEU . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 120.965 0.412 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.613 ' C ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.537 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.663 HG12 ' HE3' ' A' ' 16' ' ' MET . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.663 ' HE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.862 ' CG2' HD13 ' A' ' 55' ' ' ILE . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' CE1' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.666 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' PRO . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.865 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HD13 ' A' ' 31' ' ' LEU . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.862 HD13 ' CG2' ' A' ' 28' ' ' ILE . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.653 ' N ' HD11 ' A' ' 28' ' ' ILE . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.746 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.869 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.599 HD11 ' HB1' ' A' ' 62' ' ' ALA . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 64' ' ' PRO . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.448 HD23 ' CE ' ' A' ' 11' ' ' MET . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 76' ' ' PHE . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 15' ' ' VAL . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' MET . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' MET . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.831 ' HB3' HD13 ' A' ' 66' ' ' ILE . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 18' ' ' GLY . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 22' ' ' ILE . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' N ' ' A' ' 59' ' ' LEU . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' HD12 ' A' ' 48' ' ' LEU . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.645 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 10.9 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.759 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 60' ' ' VAL . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.885 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.853 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.686 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.831 HD13 ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.743 ' HB3' HD11 ' A' ' 9' ' ' LEU . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.831 ' HB2' HD23 ' A' ' 9' ' ' LEU . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 74' ' ' VAL . 48.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 76' ' ' PHE . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 11' ' ' MET . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.736 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' HD11 ' A' ' 22' ' ' ILE . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 55' ' ' ILE . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 51' ' ' THR . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 36' ' ' LEU . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 11.5 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 31' ' ' LEU . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.661 HD13 HG23 ' A' ' 28' ' ' ILE . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 60' ' ' VAL . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.573 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.607 ' N ' HD11 ' A' ' 28' ' ' ILE . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.726 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.784 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.78 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.696 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.48 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' MET . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 75' ' ' MET . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' ASP . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 65' ' ' MET . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.742 ' HB3' HD13 ' A' ' 66' ' ' ILE . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.713 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.808 HD11 ' N ' ' A' ' 59' ' ' LEU . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 48' ' ' LEU . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.545 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 56' ' ' VAL . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.742 HD13 ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 64' ' ' PRO . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.002 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB2' HD13 ' A' ' 9' ' ' LEU . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.778 0.323 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 11' ' ' MET . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.494 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 11' ' ' MET . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.807 ' CE ' HG23 ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.861 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 16' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.669 HD11 ' N ' ' A' ' 59' ' ' LEU . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' NZ ' ' A' ' 34' ' ' LYS . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' NZ ' HG23 ' A' ' 30' ' ' ILE . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.601 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.601 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 28' ' ' ILE . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 52' ' ' GLN . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.774 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.669 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.807 HG23 ' CE ' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 9' ' ' LEU . 14.4 t-20 . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.669 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 11' ' ' MET . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.799 ' SD ' HD12 ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HB1' ' HA2' ' A' ' 58' ' ' GLY . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' ILE . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.729 ' CG2' HD13 ' A' ' 55' ' ' ILE . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.633 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 49' ' ' LEU . 9.5 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' MET . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 31' ' ' LEU . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.729 HD13 ' CG2' ' A' ' 28' ' ' ILE . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.713 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.557 ' C ' HG22 ' A' ' 66' ' ' ILE . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.838 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD12 ' SD ' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 64' ' ' PRO . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.95 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.446 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 75' ' ' MET . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' MET . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.766 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.798 ' CG2' HD13 ' A' ' 55' ' ' ILE . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 54' ' ' PHE . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 51' ' ' THR . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.714 HG21 HD13 ' A' ' 36' ' ' LEU . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 31' ' ' LEU . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 60' ' ' VAL . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.724 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.749 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.974 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HB3' HD11 ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 6' ' ' MET . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.497 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.727 ' HE3' ' N ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 11' ' ' MET . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.85 ' SD ' HD12 ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 22' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.906 HD11 ' N ' ' A' ' 59' ' ' LEU . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.441 HD13 ' HD2' ' A' ' 54' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 35' ' ' PHE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.667 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 44' ' ' ASP . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 31' ' ' LEU . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.906 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.833 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.629 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.85 HD12 ' SD ' ' A' ' 17' ' ' MET . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 64' ' ' PRO . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.442 ' HA ' HG22 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 75' ' ' MET . 32.7 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' HD11 ' A' ' 4' ' ' LEU . 87.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.825 0.345 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.83 -26.5 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.463 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.33 -47.25 7.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.22 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 5' ' ' ASN . 2.5 pp -70.41 -10.09 58.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.62 ' N ' HD12 ' A' ' 4' ' ' LEU . 42.2 t30 -66.3 -59.52 3.63 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.448 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 75' ' ' MET . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' MET . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.591 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.751 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.744 HG23 ' HA ' ' A' ' 55' ' ' ILE . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' ' NE2' ' A' ' 42' ' ' GLN . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 47' ' ' PRO . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 4.2 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.583 ' HB2' ' HB1' ' A' ' 39' ' ' ALA . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HA ' HG23 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.613 ' N ' HD11 ' A' ' 28' ' ' ILE . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.504 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.842 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 64' ' ' PRO . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.999 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD21 ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.848 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 78' ' ' VAL . 27.1 m -158.98 101.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.079 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 11.9 mmt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.856 0.36 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -50.41 -29.48 10.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.214 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -109.24 -30.35 8.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.26 -10.22 59.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -73.16 -59.94 2.47 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 15' ' ' VAL . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 11' ' ' MET . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.886 ' CE ' HG23 ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' ILE . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.626 HD13 HG21 ' A' ' 51' ' ' THR . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' PRO . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.792 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 44' ' ' ASP . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.626 HG21 HD13 ' A' ' 36' ' ' LEU . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 31' ' ' LEU . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.636 ' HA ' HG23 ' A' ' 28' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.613 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.527 ' O ' HG12 ' A' ' 60' ' ' VAL . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.778 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.886 HG23 ' CE ' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.479 HG12 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 9' ' ' LEU . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.81 -32.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.103 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.512 0.196 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 1' ' ' MET . 40.8 mt-10 84.65 -30.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -118.52 -34.07 4.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 111.115 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.4 tm? -67.02 -21.98 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.209 0.528 . . . . 0.0 109.719 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.89 -66.2 0.61 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.961 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.613 ' C ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.537 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.663 HG12 ' HE3' ' A' ' 16' ' ' MET . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.663 ' HE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.862 ' CG2' HD13 ' A' ' 55' ' ' ILE . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' CE1' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.666 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' PRO . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.865 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HD13 ' A' ' 31' ' ' LEU . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.862 HD13 ' CG2' ' A' ' 28' ' ' ILE . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.653 ' N ' HD11 ' A' ' 28' ' ' ILE . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.746 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.869 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.599 HD11 ' HB1' ' A' ' 62' ' ' ALA . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 64' ' ' PRO . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.76 -64.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.12 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -45.83 -36.14 5.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.87 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -111.83 -32.98 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.405 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.7 mp -72.95 -8.48 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.731 0.301 . . . . 0.0 111.035 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.74 -62.28 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.448 HD23 ' CE ' ' A' ' 11' ' ' MET . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 76' ' ' PHE . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 15' ' ' VAL . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' MET . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' MET . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.831 ' HB3' HD13 ' A' ' 66' ' ' ILE . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 18' ' ' GLY . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 22' ' ' ILE . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' N ' ' A' ' 59' ' ' LEU . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' HD12 ' A' ' 48' ' ' LEU . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.645 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 10.9 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.759 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 60' ' ' VAL . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.885 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.853 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.686 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.831 HD13 ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.743 ' HB3' HD11 ' A' ' 9' ' ' LEU . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.831 ' HB2' HD23 ' A' ' 9' ' ' LEU . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 74' ' ' VAL . 48.5 t -80.57 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.8 mtt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.527 0.203 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 1' ' ' MET . 46.8 mt-10 83.79 -30.02 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.379 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -121.14 -32.52 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.617 0.246 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.4 mp -70.44 -16.64 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.178 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -70.44 -65.07 0.78 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.543 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 76' ' ' PHE . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 11' ' ' MET . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.736 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' HD11 ' A' ' 22' ' ' ILE . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 55' ' ' ILE . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 51' ' ' THR . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 36' ' ' LEU . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 11.5 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 31' ' ' LEU . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.661 HD13 HG23 ' A' ' 28' ' ' ILE . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 60' ' ' VAL . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.607 ' N ' HD11 ' A' ' 28' ' ' ILE . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.726 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.784 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.78 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.696 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.73 -64.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.083 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -49.83 -27.04 4.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.544 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.61 -38.04 6.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.3 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 4' ' ' LEU . 6.3 mp -74.58 -6.96 51.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.522 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.8 -59.71 2.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.48 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' MET . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 75' ' ' MET . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' ASP . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 65' ' ' MET . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.742 ' HB3' HD13 ' A' ' 66' ' ' ILE . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.713 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.808 HD11 ' N ' ' A' ' 59' ' ' LEU . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 48' ' ' LEU . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.545 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 56' ' ' VAL . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.742 HD13 ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 64' ' ' PRO . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.002 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB2' HD13 ' A' ' 9' ' ' LEU . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.21 -70.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.147 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.834 0.349 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -48.9 -44.73 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.504 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -88.62 -33.62 17.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.13 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -72.84 -12.16 60.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.32 -69.6 0.35 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 11' ' ' MET . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.494 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 11' ' ' MET . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.807 ' CE ' HG23 ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.861 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 16' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.669 HD11 ' N ' ' A' ' 59' ' ' LEU . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' NZ ' ' A' ' 34' ' ' LYS . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' NZ ' HG23 ' A' ' 30' ' ' ILE . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.601 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.601 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 28' ' ' ILE . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 52' ' ' GLN . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.774 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.669 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.807 HG23 ' CE ' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 79' ' ' ALA . 11.9 p -106.57 -49.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.569 0.223 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 67.02 12.22 8.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.411 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -150.75 -57.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.605 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.9 mt -71.26 -7.91 50.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.652 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 9' ' ' LEU . 14.4 t-20 -70.52 -65.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.669 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 11' ' ' MET . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.799 ' SD ' HD12 ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HB1' ' HA2' ' A' ' 58' ' ' GLY . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' ILE . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.729 ' CG2' HD13 ' A' ' 55' ' ' ILE . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.633 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 49' ' ' LEU . 9.5 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' MET . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 31' ' ' LEU . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.729 HD13 ' CG2' ' A' ' 28' ' ' ILE . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.713 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.557 ' C ' HG22 ' A' ' 66' ' ' ILE . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.838 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD12 ' SD ' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 64' ' ' PRO . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.95 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' ALA . 12.0 p -104.07 -47.55 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 5.1 mmt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.726 0.298 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 63.8 13.89 7.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.343 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -158.31 -45.5 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.82 -11.92 61.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.656 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -64.75 -60.42 3.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.446 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 75' ' ' MET . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' MET . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.766 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.798 ' CG2' HD13 ' A' ' 55' ' ' ILE . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 54' ' ' PHE . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 51' ' ' THR . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.714 HG21 HD13 ' A' ' 36' ' ' LEU . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 31' ' ' LEU . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 60' ' ' VAL . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.724 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.749 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.974 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HB3' HD11 ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 6' ' ' MET . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.73 -39.3 77.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.104 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 63.18 14.99 8.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -158.42 -44.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.711 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.8 mm? -71.12 -12.64 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.14 -68.18 0.42 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.11 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 79' ' ' ALA . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.727 ' HE3' ' N ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 11' ' ' MET . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.85 ' SD ' HD12 ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 22' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.906 HD11 ' N ' ' A' ' 59' ' ' LEU . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.441 HD13 ' HD2' ' A' ' 54' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 35' ' ' PHE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.667 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 44' ' ' ASP . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 31' ' ' LEU . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.906 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.833 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.629 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.85 HD12 ' SD ' ' A' ' 17' ' ' MET . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 64' ' ' PRO . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.442 ' HA ' HG22 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 79' ' ' ALA . 32.7 m -134.93 -46.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' ' CE ' ' A' ' 6' ' ' MET . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.448 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 75' ' ' MET . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' MET . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.591 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.751 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.744 HG23 ' HA ' ' A' ' 55' ' ' ILE . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 47' ' ' PRO . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 14.5 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.583 ' HB2' ' HB1' ' A' ' 39' ' ' ALA . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HA ' HG23 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.613 ' N ' HD11 ' A' ' 28' ' ' ILE . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.504 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.842 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 64' ' ' PRO . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.999 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD21 ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.848 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 78' ' ' VAL . 27.1 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 15' ' ' VAL . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 11' ' ' MET . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.886 ' CE ' HG23 ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' ILE . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.626 HD13 HG21 ' A' ' 51' ' ' THR . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' PRO . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.792 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 44' ' ' ASP . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.626 HG21 HD13 ' A' ' 36' ' ' LEU . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 31' ' ' LEU . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.636 ' HA ' HG23 ' A' ' 28' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.613 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.527 ' O ' HG12 ' A' ' 60' ' ' VAL . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.778 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.886 HG23 ' CE ' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.479 HG12 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 9' ' ' LEU . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 120.965 0.412 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.613 ' C ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.537 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.663 HG12 ' HE3' ' A' ' 16' ' ' MET . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.663 ' HE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.862 ' CG2' HD13 ' A' ' 55' ' ' ILE . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' CE1' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.666 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' PRO . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.865 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HD13 ' A' ' 31' ' ' LEU . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.862 HD13 ' CG2' ' A' ' 28' ' ' ILE . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.653 ' N ' HD11 ' A' ' 28' ' ' ILE . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.746 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.869 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.599 HD11 ' HB1' ' A' ' 62' ' ' ALA . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 64' ' ' PRO . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.448 HD23 ' CE ' ' A' ' 11' ' ' MET . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 76' ' ' PHE . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 15' ' ' VAL . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' MET . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' MET . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.831 ' HB3' HD13 ' A' ' 66' ' ' ILE . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 18' ' ' GLY . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 22' ' ' ILE . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' N ' ' A' ' 59' ' ' LEU . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' HD12 ' A' ' 48' ' ' LEU . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.645 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 16.4 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.759 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 60' ' ' VAL . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.885 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.853 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.686 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.831 HD13 ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.743 ' HB3' HD11 ' A' ' 9' ' ' LEU . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.831 ' HB2' HD23 ' A' ' 9' ' ' LEU . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 74' ' ' VAL . 48.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.407 ' ND2' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 76' ' ' PHE . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 11' ' ' MET . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.736 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' HD11 ' A' ' 22' ' ' ILE . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 55' ' ' ILE . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 51' ' ' THR . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 36' ' ' LEU . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 16.1 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 31' ' ' LEU . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.661 HD13 HG23 ' A' ' 28' ' ' ILE . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 60' ' ' VAL . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.573 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.607 ' N ' HD11 ' A' ' 28' ' ' ILE . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.726 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.784 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.78 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.696 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.48 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' MET . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 75' ' ' MET . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' ASP . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 65' ' ' MET . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.742 ' HB3' HD13 ' A' ' 66' ' ' ILE . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.713 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.808 HD11 ' N ' ' A' ' 59' ' ' LEU . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 48' ' ' LEU . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.545 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 56' ' ' VAL . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.742 HD13 ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 64' ' ' PRO . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.002 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB2' HD13 ' A' ' 9' ' ' LEU . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.778 0.323 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 11' ' ' MET . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.494 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 11' ' ' MET . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.807 ' CE ' HG23 ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.861 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 16' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.669 HD11 ' N ' ' A' ' 59' ' ' LEU . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' NZ ' ' A' ' 34' ' ' LYS . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' NZ ' HG23 ' A' ' 30' ' ' ILE . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.601 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.601 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 28' ' ' ILE . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 52' ' ' GLN . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.774 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.669 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.807 HG23 ' CE ' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 9' ' ' LEU . 14.4 t-20 . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.669 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 11' ' ' MET . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.799 ' SD ' HD12 ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HB1' ' HA2' ' A' ' 58' ' ' GLY . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' ILE . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.729 ' CG2' HD13 ' A' ' 55' ' ' ILE . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.633 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 49' ' ' LEU . 19.2 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' MET . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 31' ' ' LEU . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.729 HD13 ' CG2' ' A' ' 28' ' ' ILE . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.713 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.557 ' C ' HG22 ' A' ' 66' ' ' ILE . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.838 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD12 ' SD ' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 64' ' ' PRO . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.95 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.446 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 75' ' ' MET . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' MET . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.766 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.798 ' CG2' HD13 ' A' ' 55' ' ' ILE . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 54' ' ' PHE . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 51' ' ' THR . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.714 HG21 HD13 ' A' ' 36' ' ' LEU . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 49' ' ' LEU . 15.6 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 31' ' ' LEU . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 60' ' ' VAL . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.724 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.749 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.974 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HB3' HD11 ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 6' ' ' MET . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.497 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.727 ' HE3' ' N ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 11' ' ' MET . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.85 ' SD ' HD12 ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 22' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.906 HD11 ' N ' ' A' ' 59' ' ' LEU . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.441 HD13 ' HD2' ' A' ' 54' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 35' ' ' PHE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.667 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 44' ' ' ASP . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 31' ' ' LEU . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.906 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.833 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.629 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.85 HD12 ' SD ' ' A' ' 17' ' ' MET . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 64' ' ' PRO . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.442 ' HA ' HG22 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 75' ' ' MET . 32.7 m . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' HD11 ' A' ' 4' ' ' LEU . 87.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.825 0.345 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.83 -26.5 4.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.463 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.33 -47.25 7.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.22 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 5' ' ' ASN . 2.5 pp -70.41 -10.09 58.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.62 ' N ' HD12 ' A' ' 4' ' ' LEU . 42.2 t30 -66.3 -59.52 3.63 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.448 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -56.49 -27.57 57.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.075 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -70.6 -47.14 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.59 -51.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.119 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 75' ' ' MET . 23.3 tp -59.17 -57.45 12.99 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.035 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -53.13 -56.5 15.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.758 179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -58.27 -21.16 47.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.221 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.33 -51.96 38.71 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.07 -14.36 59.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.593 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.07 -38.56 16.4 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' MET . 50.3 t -78.6 -35.28 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.733 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 81.9 mtp -74.02 -52.39 12.88 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.355 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.591 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.1 mtm -75.67 -36.55 60.06 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.526 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.751 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.99 -58.16 14.07 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.274 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 85.7 mt -67.25 -26.26 66.49 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.23 -70.58 0.61 Allowed 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.588 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.82 -39.75 19.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -85.71 -32.52 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.536 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -56.84 -46.1 90.66 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.327 -1.416 . . . . 0.0 109.978 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -70.72 -48.6 53.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.769 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.34 -65.69 0.53 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.125 0.488 . . . . 0.0 110.643 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.6 mm -50.53 -46.79 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.399 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -52.22 -60.77 7.27 Favored Glycine 0 C--O 1.219 -0.824 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.224 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.744 HG23 ' HA ' ' A' ' 55' ' ' ILE . 53.7 mt -43.59 -34.7 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.316 0.579 . . . . 0.0 109.459 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.68 -42.02 40.91 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 49.7 mm -75.35 -63.73 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.247 0.546 . . . . 0.0 110.412 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -57.43 -45.35 84.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.581 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.21 -41.3 92.12 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.387 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.28 93.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -86.97 -27.55 23.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.683 0.278 . . . . 0.0 111.376 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.1 t80 -55.44 -48.14 74.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.023 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -42.68 95.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.457 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -47.47 -31.17 3.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.97 -37.35 5.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.911 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 47' ' ' PRO . . . -69.23 -25.73 64.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.73 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -66.11 -48.02 72.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.987 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 14.5 mp0 -85.26 159.0 57.34 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.917 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.46 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 10.8 Cg_endo -54.47 164.81 2.7 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.331 2.02 . . . . 0.0 111.694 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -89.06 29.16 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.04 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 tp -104.08 -50.53 3.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 111.35 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.7 mp -81.86 -56.28 0.57 Allowed Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.583 ' HB2' ' HB1' ' A' ' 39' ' ' ALA . 31.3 Cg_endo -64.44 -26.57 62.75 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.469 1.446 . . . . 0.0 112.05 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.8 tt -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.43 -49.5 54.53 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.62 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 4.9 ptt-85 -73.05 -39.28 66.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.295 0.569 . . . . 0.0 110.216 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 90.3 m -55.79 -43.01 76.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.325 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.8 pt20 -71.23 -43.8 66.6 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.324 0.583 . . . . 0.0 109.99 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' MET . 48.2 t80 -48.79 -37.67 19.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.882 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 29.5 m-85 -80.39 -55.41 4.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.411 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HA ' HG23 ' A' ' 28' ' ' ILE . 75.6 mt -48.33 -42.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.935 0.398 . . . . 0.0 110.567 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.8 t -77.64 -42.18 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.188 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 24.8 ttt -47.57 -29.57 2.96 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.648 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -90.68 -45.93 4.13 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.636 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.613 ' N ' HD11 ' A' ' 28' ' ' ILE . 77.0 mt -61.44 -15.37 36.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.0 111.344 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.0 p -97.95 -25.72 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.024 0.44 . . . . 0.0 111.438 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 57.7 t0 -66.56 -22.58 66.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.239 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -81.15 -55.55 4.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.946 0.403 . . . . 0.0 111.51 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.504 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -37.06 -38.58 0.41 Allowed Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.842 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.9 Cg_exo -82.64 -57.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.413 2.075 . . . . 0.0 111.433 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.465 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.9 mmt -58.52 -28.15 65.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.567 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 10.6 tt -80.45 -46.92 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.691 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -59.94 -34.47 73.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 64' ' ' PRO . 58.6 t -70.9 -44.21 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.199 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -64.89 -32.82 85.49 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.309 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.999 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.46 -40.49 95.79 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.931 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.13 -57.22 9.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.338 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' O ' HD21 ' A' ' 9' ' ' LEU . 87.4 mt -55.29 -35.51 65.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.921 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 20.0 t80 -69.54 -39.75 77.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.626 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -57.57 -35.15 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.848 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -63.72 -46.89 83.36 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -52.96 -35.59 59.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.789 177.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -73.09 -25.88 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 78' ' ' VAL . 27.1 m -158.98 101.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.979 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.079 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 11.9 mmt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.856 0.36 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -50.41 -29.48 10.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.214 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -109.24 -30.35 8.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.26 -10.22 59.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -73.16 -59.94 2.47 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 26.3 ptm -55.84 -28.93 58.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.905 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.65 -43.11 66.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.686 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -70.77 -48.89 51.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 76' ' ' PHE . 7.1 tt -59.33 -58.98 6.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 13.3 m-85 -54.19 -53.3 55.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.181 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 15' ' ' VAL . 47.9 tpp -55.35 -23.57 24.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.858 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.85 -50.73 39.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.408 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.35 -14.71 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.896 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.6 -37.41 14.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.552 0.691 . . . . 0.0 109.239 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 11' ' ' MET . 49.4 t -78.42 -36.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.242 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 58.5 mtt -74.26 -54.98 6.6 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.368 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.886 ' CE ' HG23 ' A' ' 66' ' ' ILE . 33.6 mtp -75.24 -38.01 60.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.79 -57.82 16.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.514 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 84.0 mt -67.87 -25.17 65.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.24 -71.51 0.54 Allowed 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.545 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.91 -39.47 19.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.01 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.1 mm -81.06 -36.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.128 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.35 -48.49 64.13 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.569 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -66.47 -49.45 66.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.14 -61.76 1.63 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 111.104 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 22' ' ' ILE . 17.6 pt -53.22 -45.96 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.208 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 26' ' ' ILE . . . -60.42 -39.42 96.23 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.861 -1.161 . . . . 0.0 112.585 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' ILE . 79.5 mt -61.03 -35.64 66.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.14 -36.22 41.16 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.254 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.35 -61.13 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.256 0.551 . . . . 0.0 110.522 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.1 mt -64.53 -38.88 92.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.747 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -75.41 -40.45 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.852 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.47 -35.54 91.21 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.971 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -89.04 -28.63 20.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 20.9 t80 -82.53 -21.42 35.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.626 HD13 HG21 ' A' ' 51' ' ' THR . 61.3 tp -74.87 -43.5 54.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.861 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.8 mm-40 -50.94 -40.77 58.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.88 97.59 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.076 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' PRO . . . -63.65 -18.21 63.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.665 0.269 . . . . 0.0 111.428 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -58.39 -38.89 78.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 111.275 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 1.5 mpp_? -85.99 -35.79 20.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.8 mm-40 -83.93 159.51 60.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 21.8 Cg_endo -61.44 154.03 61.98 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.216 1.944 . . . . 0.0 111.391 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.792 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.5 m-20 -83.3 38.66 0.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.764 0.316 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -109.25 -59.3 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.367 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 64.3 mt -83.82 -47.9 0.73 Allowed Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 39' ' ' ALA . 61.0 Cg_endo -74.52 -34.52 4.37 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.811 1.674 . . . . 0.0 112.823 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD12 ' HB3' ' A' ' 44' ' ' ASP . 5.3 tt -58.24 -39.35 78.91 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -70.09 -33.0 71.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.093 178.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.72 -47.76 29.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.752 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.626 HG21 HD13 ' A' ' 36' ' ' LEU . 79.1 m -52.58 -46.62 66.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.094 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.3 pt20 -64.71 -45.21 87.53 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.803 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 49.1 t80 -46.59 -38.55 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.899 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 31' ' ' LEU . 6.8 m-85 -72.63 -50.39 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.444 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.636 ' HA ' HG23 ' A' ' 28' ' ' ILE . 67.3 mt -49.37 -50.22 16.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.492 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.613 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 47.9 t -69.45 -41.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.02 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.527 ' O ' HG12 ' A' ' 60' ' ' VAL . 26.6 ttt -50.28 -26.41 4.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.798 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.3 -63.23 1.37 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.996 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.778 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.8 pp -50.08 -28.21 6.81 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.778 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 p -68.2 -27.6 37.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.69 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 63.6 t0 -73.87 -22.44 59.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.413 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.31 -57.01 3.56 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.215 0.531 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.8 mm -36.88 -38.57 0.4 Allowed Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 4.7 Cg_exo -82.91 -57.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.39 2.06 . . . . 0.0 111.198 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.538 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 8.9 mmt -57.51 -22.03 41.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.283 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.886 HG23 ' CE ' ' A' ' 17' ' ' MET . 70.2 mt -85.33 -44.63 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.506 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.45 77.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.479 HG12 ' C ' ' A' ' 65' ' ' MET . 13.5 p -71.83 -46.79 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.66 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -60.35 -28.89 67.85 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.367 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -75.13 -31.13 61.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.697 -0.751 . . . . 0.0 109.847 178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.98 -51.46 14.51 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.677 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' HD21 ' A' ' 9' ' ' LEU . 7.7 mp -66.79 -36.62 82.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.266 0.555 . . . . 0.0 110.386 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 15.2 t80 -69.62 -57.45 5.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.805 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.2 t -57.01 -25.68 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 50.3 ttm -63.94 -52.06 61.55 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.836 ' HB2' HD13 ' A' ' 9' ' ' LEU . 1.5 t80 -52.0 -36.56 50.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.67 -29.47 64.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -79.81 -32.59 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.019 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.103 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.512 0.196 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 1' ' ' MET . 40.8 mt-10 84.65 -30.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -118.52 -34.07 4.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.706 0.289 . . . . 0.0 111.115 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.898 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.4 tm? -67.02 -21.98 65.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.209 0.528 . . . . 0.0 109.719 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.89 -66.2 0.61 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.961 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.54 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 27.5 ptt? -52.7 -29.85 28.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.835 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.94 -48.88 56.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.298 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.613 ' C ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -61.8 -58.22 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.997 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 64.0 mt -56.52 -57.08 13.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 10.3 m-85 -56.65 -51.73 67.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.805 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.537 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.8 ttt -56.63 -23.44 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.27 -46.02 57.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.491 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -76.05 -17.53 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.022 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.3 -36.14 15.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.576 0.703 . . . . 0.0 109.336 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.663 HG12 ' HE3' ' A' ' 16' ' ' MET . 51.1 t -77.26 -38.61 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.311 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.663 ' HE3' HG12 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -73.46 -55.53 6.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 38.5 mtm -74.56 -37.09 63.07 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.69 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -61.85 -57.47 17.34 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.568 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 80.6 mt -69.11 -21.57 64.03 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -86.98 -72.17 0.52 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.194 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.82 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.95 -39.09 11.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 39.2 mm -82.65 -36.64 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.488 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.84 -46.94 74.42 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 119.714 -1.232 . . . . 0.0 110.298 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -68.79 -50.44 50.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.073 -0.563 . . . . 0.0 109.853 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.46 -63.47 1.04 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -51.84 -45.96 39.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.696 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.49 -41.63 93.49 Favored Glycine 0 C--O 1.219 -0.791 0 C-N-CA 119.712 -1.232 . . . . 0.0 111.813 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.862 ' CG2' HD13 ' A' ' 55' ' ' ILE . 70.8 mt -58.49 -34.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.12 -37.79 36.68 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.154 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.83 -62.79 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.368 0.604 . . . . 0.0 110.157 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD13 ' CE1' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -58.64 -46.56 86.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.381 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.7 -44.51 94.79 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.529 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.58 91.05 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.641 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -82.11 -42.21 19.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.545 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.666 ' CZ ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -52.79 -51.68 59.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.186 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -53.07 -43.82 67.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.01 -24.36 53.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.174 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.22 41.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.561 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' PRO . . . -175.45 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 111.272 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.76 -32.35 57.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.966 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 mpt_? -68.05 -48.18 66.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.802 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.458 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.0 mt-30 -59.95 163.4 7.76 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 87.0 Cg_exo -47.26 166.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.517 2.145 . . . . 0.0 112.368 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.63 27.92 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -106.89 -73.71 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 69.4 mt -50.98 -54.03 41.72 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.978 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 40.7 Cg_endo -65.32 -41.25 16.48 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.933 1.755 . . . . 0.0 111.542 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.865 ' O ' HD13 ' A' ' 48' ' ' LEU . 3.2 tm? -54.73 -28.39 47.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.5 OUTLIER -65.05 -51.54 60.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.511 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HD3' ' CZ ' ' A' ' 35' ' ' PHE . 3.0 ptp85 -71.98 -40.67 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.389 0.614 . . . . 0.0 109.814 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.526 ' O ' HG12 ' A' ' 55' ' ' ILE . 94.5 m -53.93 -44.12 70.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.368 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.6 pt20 -70.0 -44.23 69.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 109.958 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CE2' ' CE ' ' A' ' 57' ' ' MET . 42.5 t80 -46.04 -38.85 8.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.301 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HD13 ' A' ' 31' ' ' LEU . 15.5 m-85 -80.4 -40.69 25.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.686 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.862 HD13 ' CG2' ' A' ' 28' ' ' ILE . 30.7 mm -54.09 -41.22 49.66 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.945 0.402 . . . . 0.0 110.263 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -83.3 -41.45 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.043 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 44.8 ttm -47.68 -30.11 3.52 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -94.6 -52.7 1.79 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.727 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.653 ' N ' HD11 ' A' ' 28' ' ' ILE . 70.0 mt -54.48 -19.99 6.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.746 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 10.7 p -88.53 -32.66 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.368 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 9.8 t70 -56.95 -21.8 32.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.154 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.5 -58.37 3.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.103 0.478 . . . . 0.0 111.313 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.9 mm -31.42 -39.57 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.869 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.0 Cg_exo -83.9 -53.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.522 2.148 . . . . 0.0 111.335 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.522 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -59.07 -27.89 65.96 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.774 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.599 HD11 ' HB1' ' A' ' 62' ' ' ALA . 75.7 mt -79.14 -47.61 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.972 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -32.48 68.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 64' ' ' PRO . 62.0 t -70.69 -46.46 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.85 -29.93 76.63 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.68 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -72.92 -32.52 65.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.881 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -71.99 -52.64 10.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.632 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.12 -34.61 78.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 6.5 t80 -71.27 -59.93 2.51 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.088 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 70' ' ' LEU . 87.3 t -57.6 -22.99 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.011 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 47.6 ttm -68.27 -53.05 27.18 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.8 t80 -51.75 -36.22 46.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.01 -30.8 66.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.214 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.76 -64.6 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.12 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -45.83 -36.14 5.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.87 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -111.83 -32.98 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.405 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.7 mp -72.95 -8.48 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.731 0.301 . . . . 0.0 111.035 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.74 -62.28 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB2' ' CE2' ' A' ' 76' ' ' PHE . 20.4 ptp -50.91 -30.35 14.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.182 0.515 . . . . 0.0 109.631 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -71.05 -38.91 72.52 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.334 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.448 HD23 ' CE ' ' A' ' 11' ' ' MET . 33.7 mt -67.77 -42.95 80.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 76' ' ' PHE . 28.4 tp -58.2 -54.24 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.581 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 9.8 m-85 -54.45 -57.39 11.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 110.194 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 15' ' ' VAL . 57.9 mtm -54.93 -21.82 12.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.855 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -69.0 -49.05 61.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.034 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.43 -16.39 60.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.686 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.2 -38.3 15.4 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.59 0.71 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' MET . 46.6 t -76.67 -39.16 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.23 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' MET . 84.4 mtp -70.48 -56.31 6.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.061 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.831 ' HB3' HD13 ' A' ' 66' ' ' ILE . 53.0 mtm -72.67 -37.98 67.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.356 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -61.81 -49.44 75.97 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.848 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG22 ' A' ' 22' ' ' ILE . 96.6 mt -72.79 -28.85 62.83 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -82.91 -54.29 5.2 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.162 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.885 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -55.94 -40.74 73.6 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 18' ' ' GLY . 10.2 tp -65.63 -44.85 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 22' ' ' ILE . . . -56.1 -31.23 58.76 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.46 -1.353 . . . . 0.0 109.902 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -70.03 -55.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.835 -0.682 . . . . 0.0 110.087 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -69.4 0.21 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.709 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -48.16 -44.02 12.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.972 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -53.79 -64.36 4.3 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' N ' ' A' ' 59' ' ' LEU . 79.0 mt -44.47 -32.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.3 -41.59 45.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.003 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.4 mm -77.22 -61.91 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.217 0.532 . . . . 0.0 110.633 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 5.0 mt -59.33 -42.72 92.12 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.803 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.59 69.96 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.381 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.03 -32.75 83.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.646 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -91.77 -25.24 19.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.553 0.216 . . . . 0.0 111.527 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.83 -49.15 73.96 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.3 tp -52.02 -39.31 59.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.194 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.7 mt-10 -50.55 -49.71 55.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.614 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.19 -41.74 86.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.029 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.05 -25.48 12.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -126.82 41.22 3.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.824 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.6 mt-30 -156.03 157.7 31.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 56.2 Cg_endo -71.03 146.25 51.88 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.367 2.045 . . . . 0.0 111.762 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' HD12 ' A' ' 48' ' ' LEU . 28.0 m-20 -79.63 39.81 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.727 0.299 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -104.98 -63.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.192 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.2 mt -82.58 -47.34 0.89 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 42.0 Cg_endo -69.87 -27.6 25.75 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.688 1.592 . . . . 0.0 112.562 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 48' ' ' LEU . 4.9 tt -62.81 -41.92 99.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.645 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -66.37 -45.29 80.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.048 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 19.6 ttm180 -65.86 -51.59 57.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.997 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 62.5 m -47.71 -47.08 30.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.359 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 16.4 pt20 -65.06 -45.33 85.77 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.974 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -49.51 -36.92 24.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.624 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CE2' ' CE1' ' A' ' 35' ' ' PHE . 5.5 m-85 -78.56 -39.43 37.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 51' ' ' THR . 38.6 mm -58.84 -41.02 81.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.81 -43.64 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.799 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 58.6 ttp -51.86 -27.35 12.41 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.759 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -97.16 -26.56 10.1 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.136 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.3 tm? -81.79 -5.0 57.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 110.541 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 60' ' ' VAL . 41.2 t -126.69 9.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 8.9 t70 -75.18 -21.27 58.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.077 0.465 . . . . 0.0 110.046 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.885 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -85.44 -49.7 7.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.942 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 ' N ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mm -35.62 -37.23 0.25 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.509 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.853 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.1 Cg_exo -81.61 -59.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.064 1.843 . . . . 0.0 111.799 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.686 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 33.7 tpp -59.17 -27.46 65.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.831 HD13 ' HB3' ' A' ' 17' ' ' MET . 21.5 mm -72.43 -52.32 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.835 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.62 70.11 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.1 t -70.33 -42.17 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.261 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.16 -28.02 73.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.413 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -73.74 -31.61 63.44 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.817 -0.692 . . . . 0.0 109.75 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . . . -74.74 -48.24 13.04 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.178 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.743 ' HB3' HD11 ' A' ' 9' ' ' LEU . 87.3 mt -68.09 -39.43 82.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.239 0.542 . . . . 0.0 110.213 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 13.8 t80 -69.24 -56.17 8.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.795 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 70' ' ' LEU . 69.1 t -57.41 -26.78 27.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 56.7 ttp -62.46 -51.87 65.79 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.831 ' HB2' HD23 ' A' ' 9' ' ' LEU . 1.5 t80 -51.89 -37.14 51.18 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -62.21 -29.85 70.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.117 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 74' ' ' VAL . 48.5 t -80.57 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.8 mtt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.527 0.203 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 1' ' ' MET . 46.8 mt-10 83.79 -30.02 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.379 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -121.14 -32.52 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.617 0.246 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.4 mp -70.44 -16.64 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.178 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' ND2' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -70.44 -65.07 0.78 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.543 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 55.1 mtm -51.42 -30.96 21.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.627 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.05 -36.96 66.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.165 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 58.0 tp -68.12 -47.29 68.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 76' ' ' PHE . 9.0 mp -59.93 -55.15 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.094 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 21.4 m-85 -61.88 -57.86 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.7 ttm -54.66 -21.85 11.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -73.08 -53.44 11.05 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.684 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -70.28 -18.08 63.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -41.71 13.11 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 11' ' ' MET . 41.3 t -71.22 -41.26 74.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.39 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -70.7 -58.47 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.74 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HA ' ' A' ' 66' ' ' ILE . 44.8 mtm -67.5 -48.29 67.51 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.637 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.736 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -52.49 -55.55 21.95 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.67 -1.253 . . . . 0.0 111.051 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' HA ' HD11 ' A' ' 22' ' ' ILE . 94.6 mt -65.79 -25.98 67.49 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -81.99 -65.17 1.04 Allowed 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.496 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.9 -38.67 16.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 18' ' ' GLY . 15.2 pt -74.79 -42.38 47.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -46.81 -55.89 7.94 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.823 -1.179 . . . . 0.0 110.654 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 61' ' ' ASP . . . -65.73 -41.41 92.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -46.98 -63.12 1.12 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.2 0.524 . . . . 0.0 110.658 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.8 mt -53.07 -43.41 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.244 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.81 -42.04 94.33 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 119.648 -1.263 . . . . 0.0 111.8 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.661 HG23 HD13 ' A' ' 55' ' ' ILE . 66.6 mt -59.52 -33.85 52.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.34 -37.45 41.7 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.833 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 60.6 mt -77.83 -63.12 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.35 0.595 . . . . 0.0 110.448 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.7 mt -61.88 -41.08 97.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.74 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.47 -35.76 46.23 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.849 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.01 -41.49 97.97 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.148 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 4.0 mptp? -88.79 -33.76 17.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.516 0.198 . . . . 0.0 111.493 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 27.8 t80 -69.49 -20.82 63.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.762 0.315 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 51' ' ' THR . 65.3 tp -80.91 -30.32 35.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.544 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.87 -44.38 73.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.97 -35.55 54.03 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.118 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.44 -27.45 67.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.419 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.21 15.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.7 34.41 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.517 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 13.0 mm-40 -151.52 161.63 29.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.351 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 38.2 Cg_endo -67.17 151.55 81.12 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.028 1.819 . . . . 0.0 111.54 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.89 36.04 0.71 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.799 0.333 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.72 -54.02 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 43.6 mm -85.64 -52.38 0.47 Allowed Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 58.5 Cg_endo -72.52 -29.3 13.55 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.781 1.654 . . . . 0.0 112.325 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.8 tp -61.97 -40.85 96.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.58 -40.15 76.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.326 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -71.81 -47.06 55.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.081 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 36' ' ' LEU . 71.4 m -52.27 -47.66 65.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.341 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 16.1 pt20 -64.47 -44.92 89.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.034 0.445 . . . . 0.0 109.965 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 7.9 t80 -45.6 -40.09 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 31' ' ' LEU . 5.9 m-85 -72.38 -42.94 64.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.009 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.661 HD13 HG23 ' A' ' 28' ' ' ILE . 46.8 mm -52.95 -55.74 10.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.226 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 60' ' ' VAL . 48.7 t -67.68 -39.51 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.139 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 ttt -49.31 -31.43 9.11 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -95.35 -48.24 2.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.788 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.607 ' N ' HD11 ' A' ' 28' ' ' ILE . 82.2 mt -57.24 -18.45 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.834 0.35 . . . . 0.0 111.293 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.726 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 13.2 p -89.69 -37.3 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.527 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 t70 -42.61 -25.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.249 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -79.34 -42.24 26.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.262 0.554 . . . . 0.0 110.686 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.8 mm -39.32 -36.99 0.54 Allowed Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.784 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.1 Cg_exo -81.82 -58.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.05 1.833 . . . . 0.0 111.825 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.78 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 34.8 tpp -58.96 -29.69 67.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.696 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 72.9 mt -73.69 -44.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.119 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.0 77.68 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.3 t -66.9 -49.41 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.626 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.56 -29.3 69.26 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.486 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -71.89 -31.57 66.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.897 -0.651 . . . . 0.0 109.66 178.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.88 -54.06 7.53 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.382 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.4 mm? -64.9 -38.85 92.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.19 0.519 . . . . 0.0 110.505 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 11.0 t80 -68.23 -55.93 10.48 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.98 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 70' ' ' LEU . 76.8 t -57.07 -28.49 29.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 27.8 ttt -61.47 -51.25 69.44 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -53.13 -36.11 60.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -60.14 -30.94 69.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.038 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.73 -64.12 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.083 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -49.83 -27.04 4.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.544 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.61 -38.04 6.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.3 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 4' ' ' LEU . 6.3 mp -74.58 -6.96 51.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.522 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -70.8 -59.71 2.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.48 ' HB3' ' CE2' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -51.58 -31.67 25.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.555 178.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 11' ' ' MET . 7.3 t0 -72.91 -34.01 66.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.131 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 4' ' ' LEU . 28.7 mt -73.05 -57.01 4.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.421 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 75' ' ' MET . 85.9 mt -60.2 -48.28 82.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.035 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.6 OUTLIER -61.39 -59.22 5.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' ASP . 46.8 tpp -57.17 -20.48 26.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 110.194 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -71.02 -50.92 28.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -75.47 -14.53 60.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.718 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.55 -39.39 16.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 109.434 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.48 -37.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.706 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.46 ' O ' ' HG2' ' A' ' 65' ' ' MET . 61.2 mtt -71.62 -52.05 20.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.176 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.742 ' HB3' HD13 ' A' ' 66' ' ' ILE . 58.1 mtm -72.92 -42.69 63.22 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.856 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -57.71 -51.67 56.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.04 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.67 -39.25 93.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.713 ' HB2' ' HG2' ' A' ' 65' ' ' MET . . . -79.19 -67.17 0.78 Allowed 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.864 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -44.77 -42.21 7.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.251 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 38.0 mm -68.45 -41.92 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.37 60.09 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.154 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.46 -53.16 12.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.954 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.9 -68.59 0.19 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.583 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.2 mt -50.09 -51.83 16.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.708 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 30' ' ' ILE . . . -46.99 -68.0 1.28 Allowed Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.038 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.808 HD11 ' N ' ' A' ' 59' ' ' LEU . 69.5 mt -42.51 -34.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.228 0.537 . . . . 0.0 109.631 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.77 -42.69 61.03 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.395 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' H ' ' A' ' 31' ' ' LEU . 4.9 pt -80.82 -59.28 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.057 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -55.93 -45.76 78.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.535 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 -42.81 30.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.638 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.12 -19.24 65.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.896 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -107.68 -24.42 11.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.757 0.278 . . . . 0.0 111.626 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -57.73 -48.79 78.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.44 -49.6 24.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.354 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -55.98 -28.7 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.55 22.89 34.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -177.31 28.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.367 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.02 -35.31 37.5 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.953 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 mpt_? -69.29 -41.41 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.126 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 15.1 mp0 -67.1 159.23 77.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.905 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 34.5 Cg_endo -65.17 155.45 68.36 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.321 2.014 . . . . 0.0 111.964 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 48' ' ' LEU . 56.1 m-20 -81.79 36.75 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.624 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.0 tt -100.67 -63.16 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.044 0.449 . . . . 0.0 110.751 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 66.4 mt -80.48 -50.59 1.08 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.959 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.4 Cg_endo -69.59 -34.63 14.75 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.725 1.617 . . . . 0.0 112.202 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 64.3 tp -56.93 -39.83 75.24 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.772 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.1 -38.51 78.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.051 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CD ' ' CZ ' ' A' ' 35' ' ' PHE . 25.2 ttm180 -68.3 -56.52 8.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.863 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 96.6 m -49.21 -43.85 42.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.398 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HA ' HG12 ' A' ' 55' ' ' ILE . 14.5 pt20 -64.81 -44.29 90.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.481 0.657 . . . . 0.0 109.967 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 17.0 t80 -55.59 -33.55 64.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.381 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -80.69 -43.23 20.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.346 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.593 HG12 ' HA ' ' A' ' 52' ' ' GLN . 31.7 pt -62.66 -36.1 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.9 t -76.87 -39.94 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.7 ttt -49.9 -34.64 20.95 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.545 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -77.64 -53.82 4.86 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.815 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -53.29 -21.03 4.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.07 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 56' ' ' VAL . 66.4 t -92.68 -9.75 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.464 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.61 -22.08 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.998 0.428 . . . . 0.0 110.632 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -84.24 -57.69 3.06 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.924 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.508 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.3 mm -35.74 -37.87 0.28 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 68' ' ' VAL . 6.3 Cg_exo -81.68 -56.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.015 1.81 . . . . 0.0 111.987 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 31.9 tpp -59.14 -27.15 65.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.742 HD13 ' HB3' ' A' ' 17' ' ' MET . 28.8 mm -72.76 -55.16 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.036 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.45 64.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 64' ' ' PRO . 52.1 t -70.44 -42.9 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.301 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' CA ' ' CB ' ' A' ' 13' ' ' ALA . . . -65.23 -33.42 86.78 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.291 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.002 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.58 -40.06 94.85 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.991 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.68 -58.85 7.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.471 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -54.88 -34.39 62.94 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 109.835 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -69.82 -38.84 76.69 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.533 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 70' ' ' LEU . 89.9 t -56.5 -36.09 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB2' HD13 ' A' ' 9' ' ' LEU . 93.4 mmm -63.1 -48.43 78.63 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.0 OUTLIER -50.72 -35.71 32.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.999 177.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.17 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.21 -70.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.147 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.834 0.349 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -48.9 -44.73 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.504 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -88.62 -33.62 17.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.13 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -72.84 -12.16 60.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.025 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.32 -69.6 0.35 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.233 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 10' ' ' TYR . 23.3 mmt -52.93 -27.81 20.54 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 110.19 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 11' ' ' MET . 36.6 t70 -70.13 -41.18 74.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.131 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 61.9 tp -73.15 -53.58 10.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.674 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 93.4 mt -60.52 -49.17 78.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -64.04 -58.61 6.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.515 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.494 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 ttm -58.69 -19.58 40.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.903 0.382 . . . . 0.0 110.205 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -71.1 -56.22 6.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.469 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -69.28 -17.14 63.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.75 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.46 20.07 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 11' ' ' MET . 41.0 t -78.22 -40.97 26.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.675 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.0 mpp? -75.86 -44.41 40.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.233 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.807 ' CE ' HG23 ' A' ' 66' ' ' ILE . 56.6 mtp -79.09 -34.79 43.22 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.617 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.47 -56.22 16.45 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 119.013 -1.565 . . . . 0.0 109.722 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.861 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.4 tt -67.38 -31.44 71.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.134 -0.533 . . . . 0.0 112.379 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 16' ' ' MET . . . -88.28 -60.18 2.03 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.934 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -50.38 -37.28 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.057 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mp -81.74 -41.16 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.219 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.39 -35.59 61.4 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 119.666 -1.255 . . . . 0.0 110.372 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -72.0 -54.1 10.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.629 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.75 -68.46 0.17 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.648 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -48.16 -50.17 11.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.565 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.47 6.04 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.823 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.669 HD11 ' N ' ' A' ' 59' ' ' LEU . 62.2 mt -43.09 -34.77 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -42.54 29.45 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.061 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' NZ ' ' A' ' 34' ' ' LYS . 49.0 mm -72.86 -63.26 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.283 0.563 . . . . 0.0 110.474 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -59.98 -41.61 92.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.676 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.34 -26.93 66.86 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.646 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.0 -18.82 60.4 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.127 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' NZ ' HG23 ' A' ' 30' ' ' ILE . 60.1 mttp -109.5 -48.32 3.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.891 0.346 . . . . 0.0 111.845 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.601 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 2.4 t80 -53.04 -41.38 64.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.087 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 tp -67.8 -30.83 70.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.394 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -48.3 -55.41 10.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.92 92.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.517 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.39 -29.33 65.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.663 0.268 . . . . 0.0 111.495 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.99 82.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.4 mpt_? -64.95 -46.33 82.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.382 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -87.52 162.7 41.62 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.098 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -54.5 140.82 74.59 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.464 2.109 . . . . 0.0 111.73 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -77.13 41.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.736 0.303 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 45' ' ' LEU . 5.1 tt -110.29 -67.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 110.682 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.554 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 42.7 mm -72.54 -49.1 8.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.25 -32.51 41.91 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 121.486 1.457 . . . . 0.0 111.404 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.6 tp -58.27 -28.72 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.7 OUTLIER -66.47 -51.55 55.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.243 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.601 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 30.1 ptt180 -70.08 -39.84 75.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.141 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 95.8 m -56.78 -40.17 75.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.93 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.0 pt20 -72.86 -44.08 61.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.315 0.579 . . . . 0.0 109.852 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -50.95 -37.63 45.53 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.048 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CE2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 m-85 -82.53 -59.61 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.83 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 28' ' ' ILE . 72.9 mt -48.56 -42.34 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.149 0.499 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 52' ' ' GLN . 57.9 t -70.53 -49.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.928 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.6 ttt -48.56 -25.42 1.71 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.774 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -80.09 -53.71 4.1 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.528 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.669 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.6 pp -69.38 -4.58 18.95 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.777 0.289 . . . . 0.0 111.08 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 60' ' ' VAL . 76.2 t -106.84 0.76 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.527 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 64.0 t0 -96.47 -23.46 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.028 0.442 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -84.46 -57.78 3.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.506 0.67 . . . . 0.0 111.165 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.529 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.5 mm -40.57 -38.74 1.3 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.0 Cg_exo -81.68 -54.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.308 2.005 . . . . 0.0 111.289 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.572 ' CE ' ' HA ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -57.41 -23.94 52.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.807 HG23 ' CE ' ' A' ' 17' ' ' MET . 61.1 mt -81.58 -48.66 18.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.336 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.6 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 64' ' ' PRO . 49.0 t -72.23 -43.76 65.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.478 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -65.21 -33.78 87.81 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.217 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -64.7 -39.52 93.79 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.974 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -59.35 7.75 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.421 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.09 -34.75 66.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.426 0.631 . . . . 0.0 110.007 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 16.5 t80 -68.16 -40.42 82.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.982 HG23 ' O ' ' A' ' 70' ' ' LEU . 91.0 t -58.72 -34.57 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.1 ttt -62.7 -45.84 90.89 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.5 t80 -57.46 -32.38 66.89 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.084 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.79 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.087 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 79' ' ' ALA . 11.9 p -106.57 -49.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.569 0.223 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 67.02 12.22 8.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.411 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -150.75 -57.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.605 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.9 mt -71.26 -7.91 50.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.652 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' O ' HD13 ' A' ' 9' ' ' LEU . 14.4 t-20 -70.52 -65.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.6 mtt -49.18 -32.25 9.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 11' ' ' MET . 7.4 t0 -70.45 -38.86 74.55 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.935 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.669 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -68.74 -44.27 74.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.436 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 10.0 mp -58.62 -55.3 36.85 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 20.2 m-85 -58.84 -55.87 29.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.119 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 7' ' ' ASP . 25.4 ptm -58.14 -19.9 36.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 110.376 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -72.72 -52.1 16.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.576 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -76.5 -14.38 60.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.909 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.78 -38.35 14.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.619 0.723 . . . . 0.0 109.295 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 11' ' ' MET . 46.4 t -78.22 -37.09 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.273 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 60.7 mtt -74.17 -53.07 10.63 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.448 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.799 ' SD ' HD12 ' A' ' 66' ' ' ILE . 44.8 mtm -75.63 -38.13 59.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.28 -58.96 11.35 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.237 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 84.2 mt -66.05 -27.57 68.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -87.98 -71.6 0.57 Allowed 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.581 -0.847 . . . . 0.0 112.015 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -47.3 -39.9 15.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 1.2 mp -86.69 -33.11 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.65 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -55.23 -45.18 83.62 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.133 -1.508 . . . . 0.0 109.753 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.581 ' HB1' ' HA2' ' A' ' 58' ' ' GLY . . . -71.88 -51.04 24.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.832 -0.684 . . . . 0.0 109.952 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.34 -60.14 2.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 110.697 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' ILE . 62.1 mt -53.41 -47.87 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.64 -39.43 75.52 Favored Glycine 0 C--O 1.22 -0.758 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.847 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.729 ' CG2' HD13 ' A' ' 55' ' ' ILE . 79.2 mt -60.39 -35.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.5 -35.73 40.69 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.191 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.93 -60.88 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.408 0.623 . . . . 0.0 110.399 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.633 HD13 ' CE2' ' A' ' 54' ' ' PHE . 1.5 mt -62.47 -41.53 98.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.46 -40.63 78.98 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.019 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -43.96 97.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.279 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -79.33 -30.18 42.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.781 0.324 . . . . 0.0 110.867 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' CE2' ' HD2' ' A' ' 50' ' ' ARG . 1.2 t80 -71.09 -34.86 71.55 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.392 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.8 -40.92 94.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.1 mm-40 -54.44 -34.73 61.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.43 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.6 -46.04 75.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.967 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.05 64.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -53.38 -25.24 14.71 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.946 0.403 . . . . 0.0 111.209 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -134.75 33.33 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.833 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -154.44 162.65 26.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 39.6 Cg_exo -56.94 141.77 93.53 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.438 2.092 . . . . 0.0 111.837 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -91.28 38.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.968 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' C ' HD13 ' A' ' 45' ' ' LEU . 3.0 tm? -120.21 -49.44 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 67.3 mt -77.43 -56.12 1.22 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.687 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 42.5 Cg_endo -66.46 -39.89 15.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.705 1.603 . . . . 0.0 111.37 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.4 tp -57.12 -28.99 63.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -61.36 -53.77 52.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.113 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.614 ' HD2' ' CE2' ' A' ' 35' ' ' PHE . 20.0 ttm180 -72.5 -36.65 68.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.7 m -48.13 -42.9 30.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.813 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 49' ' ' LEU . 19.2 pt20 -74.55 -44.27 51.8 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' MET . 1.4 t80 -45.48 -33.66 2.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.837 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.633 ' CE2' HD13 ' A' ' 31' ' ' LEU . 4.2 m-85 -81.03 -47.8 13.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.145 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.729 HD13 ' CG2' ' A' ' 28' ' ' ILE . 40.7 mm -50.09 -37.49 13.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.016 0.436 . . . . 0.0 110.173 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 60' ' ' VAL . 49.6 t -85.28 -42.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.155 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 26.5 ttt -46.4 -29.67 1.8 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.994 0.426 . . . . 0.0 110.252 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' C ' HD11 ' A' ' 28' ' ' ILE . . . -100.81 -42.4 2.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.561 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 59' ' ' LEU . 3.4 tm? -56.39 -23.89 40.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.713 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.2 p -93.61 -38.36 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.632 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.7 t70 -42.53 -26.46 0.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -77.44 -48.46 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.912 0.386 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.557 ' C ' HG22 ' A' ' 66' ' ' ILE . 3.7 mm -34.26 -39.9 0.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.838 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.7 Cg_endo -83.83 -60.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.094 1.863 . . . . 0.0 111.346 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.507 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 6.5 mmt -59.21 -22.94 61.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.71 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD12 ' SD ' ' A' ' 17' ' ' MET . 11.3 tp -83.05 -47.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.109 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -61.63 -32.28 72.41 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 64' ' ' PRO . 57.6 t -71.94 -44.57 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.387 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -64.85 -36.69 93.4 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.357 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.95 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -66.13 -33.95 76.93 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.783 -0.709 . . . . 0.0 109.799 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.06 -60.71 5.78 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.499 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' MET . 81.1 mt -52.92 -36.8 60.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.644 0.735 . . . . 0.0 109.867 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 18.1 t80 -65.92 -44.44 85.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.334 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 70' ' ' LEU . 90.4 t -62.73 -30.87 50.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.592 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 26.3 mmt -60.76 -48.95 79.46 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 1.5 t80 -58.79 -32.92 69.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -57.45 -33.45 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.418 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 79' ' ' ALA . 12.0 p -104.07 -47.55 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 111.216 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 78' ' ' VAL . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 5.1 mmt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.726 0.298 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 63.8 13.89 7.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.343 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -158.31 -45.5 0.06 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.82 -11.92 61.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.656 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -64.75 -60.42 3.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.446 ' HG3' ' CD2' ' A' ' 76' ' ' PHE . 3.2 mpp? -56.02 -26.56 49.3 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.988 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.34 -51.95 31.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.638 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 8' ' ' LEU . 5.0 tt -67.03 -53.1 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 75' ' ' MET . 30.7 tp -55.37 -58.52 7.38 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.082 0.468 . . . . 0.0 111.394 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -52.16 -57.57 9.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.02 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 65.0 mtt -58.41 -19.0 32.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.516 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -68.94 -51.69 37.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.184 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -78.37 -14.14 59.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.485 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.19 -37.49 17.25 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' MET . 48.9 t -79.6 -35.44 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.732 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 57.6 mtt -73.85 -52.21 13.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.162 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.2 mtm -75.46 -39.26 58.96 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.503 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -60.81 -55.63 28.75 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.402 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.893 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -66.87 -28.35 68.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -83.79 -71.26 0.51 Allowed 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.558 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.766 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -46.88 -39.66 12.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 42.9 mm -80.9 -34.08 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.56 -47.23 78.3 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.419 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.747 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . . . -69.21 -48.39 62.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.87 -63.24 1.12 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 110.532 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.56 -42.2 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.315 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.0 -60.8 8.18 Favored Glycine 0 C--O 1.219 -0.817 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.995 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.798 ' CG2' HD13 ' A' ' 55' ' ' ILE . 63.7 mt -45.49 -33.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.47 -41.37 44.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.683 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.63 -63.81 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.311 0.577 . . . . 0.0 110.699 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 54' ' ' PHE . 3.4 mt -62.08 -42.08 98.84 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.011 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 28' ' ' ILE . . . -76.71 -38.78 30.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.901 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.5 79.98 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.915 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -93.08 -29.22 15.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.732 0.301 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 50' ' ' ARG . 21.1 t80 -75.91 -22.31 56.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.196 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 51' ' ' THR . 64.8 tp -80.68 -31.4 36.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -52.33 -59.78 4.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.14 -32.55 71.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.427 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.43 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.394 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 10.3 mpt_? -66.06 -45.5 81.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 98.9 mm-40 -87.25 164.02 37.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 54.0 Cg_exo -52.46 151.56 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.369 2.046 . . . . 0.0 111.9 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.76 35.05 0.77 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.079 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.5 tp -105.95 -55.78 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.443 . . . . 0.0 111.237 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 47' ' ' PRO . 44.0 mm -80.9 -53.55 0.8 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 53.2 Cg_endo -70.1 -33.5 15.18 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.322 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' O ' HD13 ' A' ' 48' ' ' LEU . 2.9 tm? -59.34 -40.17 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -68.8 -34.62 75.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.882 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -75.2 -42.47 55.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.003 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.714 HG21 HD13 ' A' ' 36' ' ' LEU . 80.0 m -54.36 -48.72 71.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 49' ' ' LEU . 15.6 pt20 -63.26 -44.95 93.68 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' ARG . 9.2 t80 -46.36 -36.92 6.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.619 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HE2' HD22 ' A' ' 31' ' ' LEU . 8.3 m-85 -72.69 -44.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.798 HD13 ' CG2' ' A' ' 28' ' ' ILE . 48.0 mm -51.23 -47.96 32.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.976 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . 44.9 t -71.28 -42.69 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.921 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 60' ' ' VAL . 39.0 tpp -47.1 -29.98 2.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.724 ' CA ' ' HB1' ' A' ' 24' ' ' ALA . . . -88.47 -60.15 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.569 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -52.27 -25.91 10.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.106 0.453 . . . . 0.0 110.935 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.749 ' N ' HD12 ' A' ' 59' ' ' LEU . 8.0 p -72.24 -27.87 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 62.6 t0 -75.03 -22.11 58.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.613 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . . . -82.88 -53.75 5.62 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.7 mm -39.87 -37.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.7 Cg_exo -83.19 -58.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.203 1.935 . . . . 0.0 111.488 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.511 ' CB ' ' CB ' ' A' ' 20' ' ' ALA . 5.7 mmt -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -84.19 -44.31 17.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.663 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.42 -36.29 77.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG12 ' C ' ' A' ' 65' ' ' MET . 13.3 p -72.2 -44.77 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 68' ' ' VAL . . . -61.92 -34.27 88.26 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.491 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.974 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -64.55 -41.31 96.41 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.027 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.64 -56.71 13.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.191 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.483 ' HB3' HD11 ' A' ' 9' ' ' LEU . 88.0 mt -55.57 -35.15 65.46 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.522 0.677 . . . . 0.0 109.799 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -68.85 -39.88 79.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.524 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 70' ' ' LEU . 99.0 t -57.15 -35.6 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 9' ' ' LEU . 16.3 tpt -62.35 -48.39 79.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 6' ' ' MET . 0.9 OUTLIER -51.86 -35.63 45.56 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.703 178.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.22 66.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.73 -39.3 77.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.104 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 63.18 14.99 8.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -158.42 -44.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.874 0.368 . . . . 0.0 110.711 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.8 mm? -71.12 -12.64 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -69.14 -68.18 0.42 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.11 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 79' ' ' ALA . 23.3 mmt -53.35 -27.35 23.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.034 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' MET . 7.5 t0 -69.51 -42.77 74.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.961 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 56.5 tp -71.77 -54.07 11.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.64 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 88.6 mt -59.81 -47.04 87.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.002 0.43 . . . . 0.0 111.48 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.5 OUTLIER -64.01 -59.56 4.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.54 -179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.727 ' HE3' ' N ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -59.06 -18.81 38.32 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -70.14 -55.94 8.14 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.325 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -72.04 -15.27 62.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.666 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.36 -38.18 17.69 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.606 0.717 . . . . 0.0 109.556 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 11' ' ' MET . 41.6 t -78.64 -38.23 21.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.161 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -74.32 -49.25 23.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.241 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.85 ' SD ' HD12 ' A' ' 66' ' ' ILE . 47.8 mtm -77.92 -31.89 51.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.719 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -65.75 -55.23 21.0 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.01 -1.567 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.3 tt -67.71 -33.2 74.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' CB ' ' HG2' ' A' ' 65' ' ' MET . . . -88.82 -56.51 3.26 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.102 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -54.34 -37.19 64.62 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.764 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 50.8 mm -80.72 -40.79 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.153 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.35 67.68 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.425 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . -70.51 -54.26 12.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.698 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.39 -64.88 0.68 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.688 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 22' ' ' ILE . 49.6 mt -47.78 -49.55 10.43 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.95 -61.82 5.83 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.806 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.906 HD11 ' N ' ' A' ' 59' ' ' LEU . 76.1 mt -43.95 -33.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.22 0.533 . . . . 0.0 109.614 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -42.42 29.06 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.992 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 60.1 mt -72.18 -63.15 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.098 0.475 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.441 HD13 ' HD2' ' A' ' 54' ' ' PHE . 4.6 mt -57.9 -38.34 75.67 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.659 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -27.77 66.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.405 -0.903 . . . . 0.0 112.407 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.53 -14.34 60.07 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.496 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 35' ' ' PHE . 63.7 pttt -113.69 -47.39 2.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.328 0.564 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.667 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -53.2 -31.71 44.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.3 tp -71.15 -43.84 66.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.181 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -53.84 -24.01 14.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.75 8.92 67.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.729 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -161.61 21.88 0.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.723 0.262 . . . . 0.0 111.532 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.84 68.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -78.33 -44.15 25.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.801 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 10.6 mm100 -59.62 159.4 18.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.826 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 20.6 Cg_endo -61.34 154.51 58.05 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.254 1.969 . . . . 0.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.3 p-10 -80.37 37.52 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.612 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.8 tm? -105.5 -63.08 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.004 0.43 . . . . 0.0 111.121 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 67.6 mt -78.87 -49.04 1.61 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.233 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 58.1 Cg_endo -71.49 -39.41 3.69 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.847 1.698 . . . . 0.0 112.605 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 44' ' ' ASP . 62.0 tp -60.0 -30.63 69.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.748 0.309 . . . . 0.0 110.331 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.649 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -69.16 -45.91 68.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.677 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.667 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 22.1 ptt180 -75.62 -38.83 58.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.249 0.547 . . . . 0.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' A' ' 50' ' ' ARG . 98.2 m -54.85 -42.9 72.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.039 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 15.7 pt20 -70.68 -44.54 66.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.743 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 48.2 t80 -47.42 -37.51 11.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.724 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 31' ' ' LEU . 3.3 m-85 -79.62 -46.76 16.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.684 HG23 ' CG2' ' A' ' 28' ' ' ILE . 74.0 mt -53.16 -45.42 54.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.091 0.472 . . . . 0.0 110.135 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 47.8 t -73.86 -42.22 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.579 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 53' ' ' PHE . 42.3 ttm -47.64 -30.74 3.94 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -82.61 -52.38 3.95 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.608 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.906 ' N ' HD11 ' A' ' 28' ' ' ILE . 3.3 tm? -53.35 -21.55 5.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 0.0 110.709 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 93.8 t -89.35 -15.35 8.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.043 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.45 -23.81 40.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.02 0.438 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . . . -85.28 -55.4 4.05 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 3.2 mm -38.74 -37.67 0.54 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.833 ' O ' HG23 ' A' ' 68' ' ' VAL . 5.9 Cg_exo -80.68 -53.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.869 1.713 . . . . 0.0 112.13 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.629 ' HG2' ' CB ' ' A' ' 20' ' ' ALA . 33.0 tpp -62.61 -28.98 70.27 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.276 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.85 HD12 ' SD ' ' A' ' 17' ' ' MET . 9.2 tp -74.95 -49.54 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.445 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' N ' HG23 ' A' ' 66' ' ' ILE . . . -60.27 -34.37 73.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 64' ' ' PRO . 59.4 t -72.84 -41.37 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA3' ' CG ' ' A' ' 17' ' ' MET . . . -68.03 -31.49 75.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.115 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -65.85 -39.64 90.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.947 -0.626 . . . . 0.0 109.613 178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -58.85 8.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.191 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 75' ' ' MET . 88.6 mt -55.67 -35.82 66.42 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.582 0.706 . . . . 0.0 109.831 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.9 t80 -66.83 -38.47 86.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.348 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 70' ' ' LEU . 94.8 t -58.94 -36.62 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.442 ' HA ' HG22 ' A' ' 78' ' ' VAL . 49.1 ttm -59.8 -45.44 92.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 6' ' ' MET . 1.4 t80 -59.83 -30.81 69.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.37 5.81 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 79' ' ' ALA . 32.7 m -134.93 -46.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.681 0.277 . . . . 0.0 111.555 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' ' CE ' ' A' ' 6' ' ' MET . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.174 -179.949 . . . . . . . . 1 1 . 1 stop_ save_